Borderline personality disorder (BPD) is often accompanied by other diagnoses. Some comorbidities have received a good deal of attention, but others, including somatization, have not. As effective treatments for BPD are identified, the secondary effects of these treatments on BPD comorbidities are of clinical relevance. Secondary data were used from a randomized clinical trial of dialectical behavior therapy (DBT) and community treatment by experts among 101 women with BPD in order to characterize change in somatization with treatment for BPD, and to examine emotional avoidance as a mediator. Somatization decreased significantly over time, which did not differ by treatment condition. DBT had an indirect effect on somatization through less emotional avoidance. These results suggest that the comorbid presence of significant somatization should be evaluated among those with BPD, especially in the context of emotional avoidance; treatments could be enhanced by addressing emotion regulation skills.

中文翻译：

---

治疗边缘性人格障碍和对躯体化的继发性影响。

边缘型人格障碍 (BPD) 通常伴有其他诊断。一些合并症受到了很多关注，但包括躯体化在内的其他合并症则没有。随着对 B​​PD 的有效治疗的确定，这些治疗对 BPD 合并症的次要影响具有临床相关性。二级数据来自辩证行为疗法 (DBT) 和社区治疗的随机临床试验，由专家在 101 名 BPD 女性中使用，以表征 BPD 治疗后躯体化的变化，并检查情绪回避作为中介。随着时间的推移，躯体化显着下降，这在治疗条件下没有差异。DBT 通过较少的情绪回避对躯体化产生间接影响。这些结果表明，应该在 BPD 患者中评估显着躯体化的共存情况，尤其是在情绪回避的情况下；可以通过解决情绪调节技能来加强治疗。